Research summary ·
Prognosis and therapeutic choices for occult breast cancer in female patients: a systematic review and meta-analysis.
Written based on 1 research study on PubMed, searched on 3 Nov 2026.
What was studied
This review looked at occult breast cancer in women. In this rare type, cancer shows in armpit lymph nodes. No tumour is found in the breast. The team searched PubMed, Embase and the Cochrane Library for studies after 2000. They looked at survival and treatment. The review pooled retrospective studies with 6,001 patients.
What they found
Patients with N2-3 disease had worse overall survival than those with N1 disease. The hazard ratio was 6.10. Mastectomy was not clearly linked to overall or disease-free survival. Radiotherapy was linked to better overall survival, with a hazard ratio of 0.60. No clear link was seen with disease-free survival.
What it means for patients
The authors say women with this cancer appear to have relatively favorable survival. They say armpit lymph node stage remains an important factor. They say mastectomy showed no clear survival gain. They say radiotherapy appeared linked to better survival.
Why it is not certain yet
All the studies were retrospective. The authors say the radiotherapy finding should be read with care. The evidence came mostly from retrospective observational studies. The effect of radiotherapy on disease-free survival is uncertain. The authors say more prospective studies are needed.
Source
Prognosis and therapeutic choices for occult breast cancer in female patients: a systematic review and meta-analysis.
PubMed · PMID 42958221We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Metastatic breast cancer publications